HIF‐2α induction, by contrast, has been shown to counteract HIF‐1α‐dependent cell cycle arrest in renal cell carcinoma lines, thereby resulting in enhanced proliferation dependent on c‐Myc gain‐of‐function (Gordan et al, 2007). The gene discussed is MYC; the disease is renal cell carcinoma.